Anna Protopapas, Director: Nuvalent NUVL Sell · Filed 23/12/20

Trade details

Type: Insider sale
Amount: $378,350
Shares · price: 5,000 sh · $75.67 a share
Held after: 0 sh
Stock: Nuvalent NUVL
Person: Anna ProtopapasDirector
Trade date: 23/12/18
Filed: 23/12/20
Days to filing: 2 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Nuvalent trades, last 26 weeks

What else happened in Nuvalent around then

Filed or reported within 30 days of the trade day · 23/11/18~24/01/17

Anna Protopapas's recent trades

Anna ProtopapasDirector
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$5,009
8,637 sh
$5,009
Filed 25/01/17
Traded 25/01/16
Anna ProtopapasDirector
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$3,900
6,191 sh
$3,900
Filed 25/01/16
Traded 25/01/15
Anna ProtopapasDirector
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$7,612
11,534 sh
$7,612
Filed 25/01/15
Traded 25/01/14
Anna ProtopapasDirector
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$79.7K
29,399 sh
$79.7K
Filed 24/01/17
Traded 24/01/16
Anna ProtopapasPresident & CEO
SellMersana Therapeutics
Sell
Mersana Therapeutics
MRSN
$99.6K
17,346 sh
$99.6K
Filed 23/01/18
Traded 23/01/17